Follow
Lipum AB
Nasdaq First North GM (Sweden)
Lipum AB develops a biological drug for treatment of chronic inflammatory diseases.
Sector:
HEALTH CARE
>
Biotechnology
Media
 
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
LIPUM
SE0015660899
Nasdaq First North GM
Sweden (SE)
Details of share in Lipum AB with ticker LIPUM
Status
Inactive
Order book id
Amount of instruments
Par value
Currency
SEK
First trading date
22 Apr 2021
Type
Price
Pre-money valuation
Time
Files
IPO
31.80 SEK
75.68M SEK
25 Mar - 08 Apr 2021
IPO in Lipum AB
Type
Ticker
ISIN
Market
OPTION
LIPUM TO1
SE0015810429
Nasdaq First North GM
Sweden (SE)
Details of option in Lipum AB with ticker LIPUM TO1
Status
Inactive
Order book id
Amount of instruments
Currency
SEK
First trading date
22 Apr 2021
Terms
Two (2) warrants entitles the holder to subscribe for one (1) new share for SEK 45.0 during the subscription period from August 1, 2022 - August 31, 2022.
Type
Price
Pre-money valuation
Time
Files
Exercise
45.00 SEK
01 Aug - 31 Aug 2022
Option exercise terms for LIPUM TO1
People
Einar Pontén
CEO
Ulf Björklun
Chairman of the board
Olle Hernell
Board member
Lennart Lundberg
Board member
Kristian Sandberg
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Tvistevägen 48 C
Zip code
907 36
City/district
Umeå
Country
Sweden (SE)
Registration number
556813-5999
LEI code
549300V7JL0004BHBD93
First trade date
22 Apr 2021
Registration date
02 Jul 2010
Short name
Lipum

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More